ArticleNature communications2020
Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds.
Abstract readPublished Erratum
In one paragraph
Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Discovery of Novel Synthetic Cyclohexene-Based Small Molecules Targeting Senescence against Age-Related Pulmonary Fibrosis.Journal of medicinal chemistry · 2026Article
- The Role of Cellular Senescence and SASP in the Pathogenesis of Atherosclerosis and the Therapeutic Potential of Senolytic Strategies in Cardiovascular Diseases.Biomedicines · 2026Review
- LncDARS-AS1 Regulates ATP1A1 Stability and Enhances NaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Mild Uncoupling of Mitochondria Synergistically Enhances Senolytic Specificity and Sensitivity of BH3 Mimetics.Aging biology · 2024Article
Corrections and comments
- Erratum for
Authors and funding
27 authors.
Francisco Triana-Martínez *Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.
Pilar Picallos-Rabina *Laboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0001-5673-5952
Sabela Da Silva-ÁlvarezLaboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.
Federico PietrocolaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain.
Susana LlanosDNA Replication Group, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-8555-9326
Verónica RodillaPreclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0512-4179
Enrica SopranoCentro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS) and Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0001-6786-9729
Pablo PedrosaLaboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.
Alba FerreirósLaboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-7003-8683
Marta BarradasMetabolic Syndrome Group, Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC, Madrid, E28049, Spain.ORCID http://orcid.org/0000-0001-7122-7251
Fernanda Hernández-GonzálezInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain.
Marta LalindePreclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain.
Neus PratsInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain.
Cristina BernadóPreclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain.
Patricia GonzálezHistopathology Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
María GómezHistopathology Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Maria P IkonomopoulouTranslational Venomics Group, Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC, Madrid, E28049, Spain.ORCID http://orcid.org/0000-0001-7739-080X
Pablo J Fernández-MarcosMetabolic Syndrome Group, Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC, Madrid, E28049, Spain.ORCID http://orcid.org/0000-0003-3515-4125
Tomás García-CaballeroDepartamento de Ciencias Morfológicas, Facultad de Medicina. USC. Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.
Pablo Del PinoCentro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS) and Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0003-1318-6839
Joaquín ArribasPreclinical Research Program, Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC, Barcelona, Spain.
Anxo VidalCiCLOn, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), E15782, Santiago de Compostela, Spain.
Miguel González-BarciaServicio de Farmacia, Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain.
Manuel SerranoInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7177-9312
María I LozaBioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Eduardo DomínguezBioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. eduardo.dominguez@usc.es.ORCID http://orcid.org/0000-0003-3359-5867
Manuel ColladoLaboratory of Stem Cells in Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), E15706, Santiago de Compostela, Spain. manuel.collado.rodriguez@sergas.es.ORCID http://orcid.org/0000-0002-0330-0880
Funding
No grant is acknowledged in the PubMed record.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.